Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A review of glioblastoma immunotherapy.
Medikonda R, Dunn G, Rahman M, Fecci P, Lim M. Medikonda R, et al. J Neurooncol. 2021 Jan;151(1):41-53. doi: 10.1007/s11060-020-03448-1. Epub 2020 Apr 6. J Neurooncol. 2021. PMID: 32253714 Review.
Alternative Checkpoints as Targets for Immunotherapy.
Pant A, Medikonda R, Lim M. Pant A, et al. Among authors: medikonda r. Curr Oncol Rep. 2020 Nov 3;22(12):126. doi: 10.1007/s11912-020-00983-y. Curr Oncol Rep. 2020. PMID: 33141349 Free PMC article. Review.
Development of new brain metastases in triple negative breast cancer.
Medikonda R, Srivastava S, Kim T, Xia Y, Kim J, Jackson C, Weingart J, Mukherjee D, Bettegowda C, Gallia G, Brem H, Redmond K, Stearns V, Kleinberg L, Lim M. Medikonda R, et al. J Neurooncol. 2021 Apr;152(2):333-338. doi: 10.1007/s11060-021-03702-0. Epub 2021 Jan 29. J Neurooncol. 2021. PMID: 33512631
Synergy between glutamate modulation and anti-programmed cell death protein 1 immunotherapy for glioblastoma.
Medikonda R, Choi J, Pant A, Saleh L, Routkevitch D, Tong L, Belcaid Z, Kim YH, Jackson CM, Jackson C, Mathios D, Xia Y, Shah PP, Patel K, Kim T, Srivastava S, Huq S, Ehresman J, Pennington Z, Tyler B, Brem H, Lim M. Medikonda R, et al. J Neurosurg. 2021 Aug 13;136(2):379-388. doi: 10.3171/2021.1.JNS202482. Print 2022 Feb 1. J Neurosurg. 2021. PMID: 34388730
Combination checkpoint therapy with anti-PD-1 and anti-BTLA results in a synergistic therapeutic effect against murine glioblastoma.
Choi J, Medikonda R, Saleh L, Kim T, Pant A, Srivastava S, Kim YH, Jackson C, Tong L, Routkevitch D, Jackson C, Mathios D, Zhao T, Cho H, Brem H, Lim M. Choi J, et al. Among authors: medikonda r. Oncoimmunology. 2021 Aug 29;10(1):1956142. doi: 10.1080/2162402X.2021.1956142. eCollection 2021. Oncoimmunology. 2021. PMID: 34484870 Free PMC article.
Mutation status and postresection survival of patients with non-small cell lung cancer brain metastasis: implications of biomarker-driven therapy.
Shah PP, Franke JL, Medikonda R, Jackson CM, Srivastava S, Choi J, Forde PM, Brahmer JR, Ettinger DS, Feliciano JL, Levy BP, Marrone KA, Naidoo J, Redmond KJ, Kleinberg LR, Lim M. Shah PP, et al. Among authors: medikonda r. J Neurosurg. 2021 Jun 4;136(1):56-66. doi: 10.3171/2020.10.JNS201787. Print 2022 Jan 1. J Neurosurg. 2021. PMID: 34087798
24 results